P072 Activity and clinical outcomes of New Agents (NAs) administered as third or fourth line after the failure of docetaxel (DOC) and another NA in metastatic Castration-Resistant Prostate Cancer (mCRPC) patients. Final results of an Italian multicentre retrospective study
Autor: | Daniele Alesini, Roberto Sabbatini, Donata Sartori, Cinzia Ortega, Orazio Caffo, Vincenza Conteduca, G. Procopio, U. De Giorgi, Umberto Basso, Francesca Maines, Paolo Andrea Zucali, L. Fratino, Francesco Verderame, Franco Morelli, Marco Tucci, Enrico Campadelli, Gaetano Facchini, Maddalena Donini, Donatello Gasparro, G. Lo Re, Enzo Galligioni |
---|---|
Rok vydání: | 2014 |
Předmět: | |
Zdroj: | European Urology Supplements. 13:135-136 |
ISSN: | 1569-9056 |
Databáze: | OpenAIRE |
Externí odkaz: |